NYSE:MDTMedical Equipment
Medtronic Spin Of MiniMed Highlights Refocused Growth And Capital Priorities
Medtronic (NYSE:MDT) has completed the initial public offering of its MiniMed diabetes unit, creating a standalone publicly traded company.
The separation formally reshapes Medtronic’s portfolio, with diabetes now operating as an independent business in public markets.
Alongside the MiniMed IPO, Medtronic reports its strongest top-line performance in a decade and is pursuing targeted investments and M&A.
For you as an investor, this move changes how Medtronic is structured and where its...